Comparative Pharmacology
Head-to-head clinical analysis: METHADOSE versus PHERAZINE VC W CODEINE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: METHADOSE versus PHERAZINE VC W CODEINE.
METHADOSE vs PHERAZINE VC W/ CODEINE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Methadone is a mu-opioid receptor agonist; it also acts as an NMDA receptor antagonist and inhibits serotonin and norepinephrine reuptake, contributing to its analgesic and detoxification effects. It has a long half-life and reduces opioid craving and withdrawal symptoms.
Codeine: Opioid receptor agonist (mu-receptor), suppresses cough reflex. Phenylephrine: Alpha-1 adrenergic receptor agonist, vasoconstrictor. Promethazine: Histamine H1 receptor antagonist, anticholinergic, antiemetic.
Oral: 20-40 mg once daily, titrated to effect; for opioid dependence, typical maintenance 80-120 mg/day. IV: 2.5-10 mg every 8-12 hours.
Adults: 5 mL (one teaspoonful) orally every 4 to 6 hours as needed; each 5 mL contains promethazine hydrochloride 5 mg, phenylephrine hydrochloride 5 mg, and codeine phosphate 10 mg. Maximum daily dose: codeine 120 mg (6 doses).
None Documented
None Documented
Terminal elimination half-life range: 8–59 hours (mean ~20–35 hours). In chronic use, half-life may increase due to accumulation. Context: The long half-life supports once-daily dosing for opioid dependence but requires careful titration to avoid accumulation.
Codeine: 2.5-3.5 hours (terminal); phenylephrine: 2-3 hours; promethazine: 10-19 hours (clinical context: prolonged in renal impairment, accumulation with chronic use).
Primarily renal (approximately 80%) as inactive metabolites, with about 20% eliminated via feces. Less than 10% excreted unchanged.
Renal: codeine (40-70% as free and conjugated metabolites, including morphine, norcodeine, and hydromorphone); phenylephrine (80-90% as conjugated metabolites, 10% unchanged); promethazine (primarily as sulfoxides and glucuronides, renal elimination about 70%). Fecal/biliary: minor.
Category C
Category D/X
Opioid Agonist
Opioid Agonist